The Impact of Hyperglycemic Emergencies on the Kidney and Liver
Table 1
Clinical and biochemical characteristics of the study participants before and after treatment.
Variables
Controls ()
Stable patient ()
Total DK, before ()
Total DKA, before ()
Total DK, after ()
Total DKA, after ()
Female/male ()
20/20
17/23
14/26
22/18
—
—
Age (years)
—
—
Diabetic type (1/2)
N/A
17/23
18/22
19/21
—
—
Duration of diabetes (years)
N/A
4.00 (0.00–20.00)
(0.00–12.00)
(0.00–26.00)
—
—
—
—
Plasma glucose (mmol/L)
HbA1c (%)
—
—
Alanine aminotransferase (U/L)
Aspartate aminotransferase (U/L)
-glutamyl transpeptidase (U/L)
Total bilirubin (μmol/L)
Direct bilirubin (μmol/L)
Total protein (g/L)
Albumin (g/L)
Globulin (g/L)
Prealbumin (mg/L)
Serum creatinine (μmol/L)
eGFR (mL/min per 1.73 m2)
Uric acid (μmol/L)
Comparison with control group: , ; comparison with stable DM group: , ; comparison with total DK group: , ; comparison with pretreatment: , . All values in the table are given as the mean ± standard deviation, except for the duration of diabetes, which is given as the median and range (min–max).